Rossi Christina
Insider CIK 1756941 · BPMC Chief Operating Officer · XLO Director · CGON Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CGON CG Oncology, Inc. | A Award deriv | 2026-06-04 | 2026-06-05 | 9,354 | — | $0 | 9,354 | SEC↗ |
| CGON CG Oncology, Inc. | A Award deriv | 2025-11-24 | 2025-11-26 | 20,889 | — | $0 | 20,889 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,125 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 28,500 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 6,500 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 80,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,400 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 30,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 30,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 30,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-07-17 | 2025-07-21 | 39,456 | — | $0 | 103,002 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer | 2025-07-17 | 2025-07-21 | 82,374 | — | $0 | 20,628 | SEC↗ |
| BPMC Blueprint Medicines Corp | U Tender | 2025-07-17 | 2025-07-21 | 20,628 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-07-03 | 2025-07-08 | 1,172 | $128.25 | $150.3K | 63,546 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 31,000 | — | $0 | 31,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-05-19 | 2025-05-21 | 1,413 | $100.67 | $142.2K | 64,775 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-05-19 | 2025-05-21 | 57 | $101.72 | $5.8K | 64,718 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-05-19 | 2025-05-21 | 804 | $100.14 | $80.5K | 66,188 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-05-05 | 2025-05-07 | 607 | $100.97 | $61.3K | 68,659 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-05-05 | 2025-05-07 | 180 | $102.82 | $18.5K | 67,136 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-05-05 | 2025-05-07 | 144 | $103.56 | $14.9K | 66,992 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-05-05 | 2025-05-07 | 1,343 | $101.77 | $136.7K | 67,316 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-03-24 | 2025-03-26 | 2,274 | $95.02 | $216.1K | 69,266 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-03-05 | 2025-03-07 | 6,495 | $88.80 | $576.8K | 71,540 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2025-03-01 | 2025-03-04 | 26,400 | — | $0 | 26,400 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-03-01 | 2025-03-04 | 13,200 | — | $0 | 78,035 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-02-20 | 2025-02-24 | 2,274 | $95.14 | $216.3K | 64,835 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-01-21 | 2025-01-23 | 529 | $108.99 | $57.7K | 68,854 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-01-21 | 2025-01-23 | 816 | $110.00 | $89.8K | 68,038 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-01-21 | 2025-01-23 | 808 | $110.78 | $89.5K | 67,230 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-01-21 | 2025-01-23 | 121 | $111.81 | $13.5K | 67,109 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-12-18 | 2024-12-20 | 2,166 | $95.88 | $207.7K | 69,491 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-12-18 | 2024-12-20 | 108 | $96.50 | $10.4K | 69,383 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-11-27 | 2024-12-02 | 2,274 | $95.10 | $216.3K | 71,657 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2024-07-01 | 2024-07-08 | 9,625 | — | $0 | 73,931 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2024-06-14 | 2024-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-03-07 | 2024-03-11 | 6,070 | $90.69 | $550.5K | 64,306 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2024-03-01 | 2024-03-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2024-03-01 | 2024-03-06 | 15,000 | — | $0 | 70,376 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2023-06-12 | 2023-06-13 | 13,200 | — | $0 | 13,200 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-03-06 | 2023-03-08 | 2,960 | $45.72 | $135.3K | 55,475 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-03-06 | 2023-03-08 | 99 | $44.28 | $4.4K | 55,376 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2023-03-01 | 2023-03-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2023-03-01 | 2023-03-03 | 15,000 | — | $0 | 58,435 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-11-03 | 2022-11-07 | 533 | $45.24 | $24.1K | 43,435 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 13,200 | — | $0 | 13,200 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-03-07 | 2022-03-08 | 1,047 | $56.19 | $58.8K | 44,479 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-03-03 | 2022-03-08 | 1,197 | $60.28 | $72.2K | 45,526 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2022-03-01 | 2022-03-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2022-03-01 | 2022-03-03 | 15,000 | — | $0 | 46,723 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-11-03 | 2022-03-23 | 511 | $110.85 | $56.6K | 43,968 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-04 | 2021-03-05 | 87 | $89.10 | $7.8K | 32,995 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-04 | 2021-03-05 | 1,272 | $86.61 | $110.2K | 31,723 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2021-03-01 | 2021-03-03 | 26,125 | — | $0 | 26,125 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2021-03-01 | 2021-03-03 | 13,062 | — | $0 | 33,082 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-11-03 | 2020-11-05 | 345 | $99.69 | $34.4K | 20,020 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-03-09 | 2020-03-11 | 135 | $51.96 | $7.0K | 20,365 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2020-03-01 | 2020-03-03 | 28,500 | — | $0 | 28,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2020-03-01 | 2020-03-03 | 14,250 | — | $0 | 20,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-11-01 | 2019-11-05 | 1,125 | — | $0 | 3,375 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-11-01 | 2019-11-05 | 1,125 | — | $0 | 1,125 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-03-01 | 2019-03-05 | 6,500 | — | $0 | 6,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-03-01 | 2019-03-05 | 1,750 | — | $0 | 1,750 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2018-11-01 | 2018-11-05 | 80,000 | — | $0 | 80,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2018-11-01 | 2018-11-05 | 4,500 | — | $0 | 4,500 | SEC↗ |